Aclarion Launches New Jersey Network Using Nociscan Technology for Objective Chronic Low Back Pain Evaluation in Legal Cases

Aclarion, Inc., a healthcare technology company, has announced an initiative to develop a statewide network of providers in New Jersey that will utilize its Nociscan technology to evaluate chronic low back pain in personal injury and workers compensation cases. The program, led by Dr. Justin Kubeck, aims to improve the objective evaluation of patients within these complex systems, where settlements can be substantial. In New Jersey, the average settlement for personal injury claims involving the neck and back is $918,967, while work-related accidents causing such injuries have a national average settlement of $148,750.

Nociscan uses Magnetic Resonance Spectroscopy (MRS) and proprietary AI algorithms to help physicians identify the location of chronic low back pain by providing objective data on biomarkers in the lumbar disc correlated to pain and structural integrity. Dr. Kubeck emphasized the technology's legal importance, stating, "The nature of these claims mandates an objective and definitive diagnosis, knowing that the diagnosis may well be challenged in a legal setting. The use of Nociscan can be a powerful objective measurement tool to provide a strong case for supporting an appropriate treatment pathway."

The initiative has broader implications, as Ryan Bond, Chief Strategy Officer of Aclarion, indicated plans to target other U.S. markets after establishing the New Jersey network, which could impact how chronic low back pain is evaluated nationwide. Nociscan works by receiving MRS data from an MRI machine for each lumbar disc, with proprietary signal processing techniques extracting and quantifying chemical biomarkers associated with disc pain; this data is then analyzed by algorithms to indicate if a disc may be a pain source.

The potential impact on healthcare and legal sectors is significant, as Nociscan provides more objective data in cases often reliant on subjective pain assessments, potentially streamlining evaluations, leading to more accurate diagnoses, appropriate treatments, and fair compensation. For the medical community, it offers a new tool in chronic pain management, while for the legal system, it provides a robust basis for decision-making. Patients could benefit from faster, more accurate diagnoses and effective treatment plans. If successful, this approach may set a new standard for evaluating chronic low back pain in legal and medical contexts.